VOLUME 62   2001   NUMBER 3

Brainstorms

147 The Psychopharmacology of Sex, Part 2: Effects of Drugs and Disease on the 3 Phases of Human Sexual Response. Stephen M. Stahl
[PDF]

ORIGINAL ARTICLES

149 Pharmacologic Treatment of Anxiety Disorders in 1989 Versus 1996: Results From the Harvard/Brown Anxiety Disorders Research Program. Carl Salzman, Idell Goldenberg, Steven E. Bruce, and Martin B. Keller
[Abstract] [PDF]

153 Risperidone Liquid Concentrate and Oral Lorazepam Versus Intramuscular Haloperidol and Intramuscular Lorazepam for Treatment of Psychotic Agitation. Glenn W. Currier and George M. Simpson
[Abstract] [PDF]

158 Which Depressed Patients Respond to Nefazodone and When? Madhukar H. Trivedi, A. John Rush, Ji-Yang Pan, and Thomas J. Carmody
[Abstract] [PDF]

164 An Open Trial of Light Therapy for Women With Seasonal Affective Disorder and Comorbid Bulimia Nervosa. Raymond W. Lam, Susan K. Lee, Edwin M. Tam, Arvinder Grewal, and Lakshmi N. Yatham
[Abstract] [PDF]

169 Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Posttraumatic Stress Disorder. Ofer Agid, Arieh Y. Shalev, and Bernard Lerer
[Abstract] [PDF]

174 Incidence and Consistency of Antiretroviral Use Among HIV-Infected Medicaid Beneficiaries With Schizophrenia. James Walkup, Usha Sambamoorthi, and Stephen Crystal
[Abstract] [PDF]

179 A Comparison of Long-Term Outcome in First-Episode Schizophrenia Following Treatment With Risperidone or a Typical Antipsychotic. Ashok K. Malla, Ross M. G. Norman, Derek J. Scholten, Sandra Zirul, and Vinod Kotteda
[Abstract] [PDF]

185 Substitution of an SSRI With Bupropion Sustained Release Following SSRI-Induced Sexual Dysfunction. Anita H. Clayton, Elizabeth L. McGarvey, Ahmed I. Abouesh, and Relana C. Pinkerton
[Abstract] [PDF]

191 Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis. Joerg Czekalla, Charles M. Beasley, Jr., Mary Anne Dellva, Paul H. Berg, and Starr Grundy
[Abstract] [PDF]

199 A Preliminary Double-Blind, Placebo-Controlled Trial of Divalproex Sodium in Borderline Personality Disorder. Eric Hollander, Andrea Allen, Rita Prieto Lopez, Carol A. Bienstock, Robert Grossman, Larry J. Siever, Lisa Merkatz, and Dan J. Stein
[Abstract] [PDF]

CME Article 211

212 The Clinical Features of Bipolar Depression: A Comparison With Matched Major Depressive Disorder Patients. Philip B. Mitchell, Kay Wilhelm, Gordon Parker, Marie-Paule Austin, Philip Rutgers, and Gin S. Malhi
[Abstract] [PDF]

LETTERS TO THE EDITOR

204 Fatal Body Dysmorphic Disorder by Proxy. Naureen Atiullah and Katharine A. Phillips
[PDF]

205 Treatment of Refractory Major Depression With Tramadol Monotherapy. Nathan Andrew Shapira, Marcia L. Verduin, and John D. DeGraw
[PDF]

206 Emergence of PTSD in Trauma Survivors With Dementia. Margriet E. van Achterberg, Robert M. Rohrbaugh, and Steven M. Southwick
[PDF]

207 Physical Restraints, Thromboembolism,and Death in 2 Patients. Arthur Lazarus
[PDF]

208 Lithium Intoxication After Administration of AT1 Blockers. Peter Zwanzger, Alain Marcuse, Reinhard J. Boerner, Axel Walther, and Rainer Rupprecht
[PDF]

209 Corrections. Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP. Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients (J Clin Psychiatry 2001;62:12-18); Nizny MM. Review of Allen JG: Coping With Trauma: A Guide to Self-Understanding (J Clin Psychiatry 2000;61:953-954)
[PDF]

Book Reviews 210

Information for authors

see January 2001, pages 75-77 or our Web site at www.psychiatrist.com/author.htm

View other Tables of Contents | Home